Wednesday, 27 January 2021
Immuno-metabolism and cognitive decline

Immunology research update from Immunopaedia.org.zaMinhas et al. investigated whether an increase in PGE2 is associated with the development of age-associated maladaptive inflammation and cognitive decline. They focused their research on PGE2 because levels of PGE 2 are increased during neurodegenerative diseases and in monocytes from older (<65 yrs) compared to younger individuals (< 35 yrs).

Publication Date:
Mon, 25 Jan 2021 - 18:00
Ad26.COV2.S is safe and immunogenic

COVID-19 and SARS-CoV-2 update from Immunopaedia.org.za Interim analysis indicates that vaccine candidate Ad26.COV2.S is safe and immunogenic in both younger and older adults. This finding, in combination with the results in preclinical challenge studies, has supported our decision to proceed with phase 3 trials to evaluate the efficacy of a single or two-dose regimen of 5×10^10 viral particles of Ad26.COV2.S.

Publication Date:
Fri, 22 Jan 2021 - 17:00
Webinar: Determinants of HIV persistence: barriers and progress to and HIV cure

This webinar will be hosted in order to discuss HIV cure research; more specifically, the latest findings on how host immunity plays a role in HIV persistence and perhaps how to exploit what we know to formulate cure strategies. 26th January at 17h00 GMT+2 (South Africa)

Publication Date:
Tue, 19 Jan 2021 - 16:45
SARS-CoV-2-specific Memory B cells persist up to 8 months post infection

COVID-19 and SARS-CoV-2 update from Immunopaedia.org.zaStudies by Hartley et al., & Dan et al., provide hope for long-lasting memory B cell immunity which persists despite a decline in circulating SARS-CoV-2-antibodies. Further, they highlight specific immune compartment that could be used as better markers of persisting immunity.

Publication Date:
Tue, 19 Jan 2021 - 16:30